title: PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Black
authors.forename: Salvatore
authors.initials: S
authors.lastname: Lopez
authors.forename: Emiliano
authors.initials: E
authors.lastname: Cocco
authors.forename: Stefania
authors.initials: S
authors.lastname: Bellone
authors.forename: Gary
authors.initials: G
authors.lastname: Altwerger
authors.forename: Carlton L
authors.initials: CL
authors.lastname: Schwab
authors.forename: Diana P
authors.initials: DP
authors.lastname: English
authors.forename: Elena
authors.initials: E
authors.lastname: Bonazzoli
authors.forename: Federica
authors.initials: F
authors.lastname: Predolini
authors.forename: Francesca
authors.initials: F
authors.lastname: Ferrari
authors.forename: Elena
authors.initials: E
authors.lastname: Ratner
authors.forename: Dan-Arin
authors.initials: DA
authors.lastname: Silasi
authors.forename: Masoud
authors.initials: M
authors.lastname: Azodi
authors.forename: Peter E
authors.initials: PE
authors.lastname: Schwartz
authors.forename: Alessandro D
authors.initials: AD
authors.lastname: Santin